Literature DB >> 5138752

Hypokalaemic myopathy and myoglobinuria due to carbenoxolone sodium.

P C Barnes, J H Leonard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5138752      PMCID: PMC2467370          DOI: 10.1136/pgmj.47.554.813

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.

Authors:  A G Turpie; T J Thomson
Journal:  Gut       Date:  1965-12       Impact factor: 23.059

2.  Pseudohyperaldosteronism induced by habitual ingestion of liquorice.

Authors:  A M Holmes; J Young; P K Marrott; E Prentice
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

3.  Muscle paresis and hypokalemia after treatment with duogastrone.

Authors:  J Forshaw
Journal:  Br Med J       Date:  1969-06-14

4.  Myopathy and hypokalaemia in carbenoxolone therapy.

Authors:  T Fyfe; K M Cochran; T B Begg
Journal:  Br Med J       Date:  1969-08-23

5.  Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone).

Authors:  S D Mohamed; R S Chapman; J Crooks
Journal:  Br Med J       Date:  1966-06-25

6.  Hypokalemic myopathy with myoglobinuria associated with licorice ingestion.

Authors:  E G Gross; J D Dexter; R G Roth
Journal:  N Engl J Med       Date:  1966-03-17       Impact factor: 91.245

7.  Hypokalaemia complicating carbenoxolone (duogastrone) therapy.

Authors:  A Muir; J A Laithwaite; W Wood
Journal:  Br Med J       Date:  1969-05-24

8.  Hypokalemia after treatment with duogastrone (carbenoxolone).

Authors:  M Swallow
Journal:  Br Med J       Date:  1969-07-26
  8 in total
  4 in total

Review 1.  Clinical features, pathogenesis and management of drug-induced rhabdomyolysis.

Authors:  C Köppel
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 2.  Some aspects of medical management of gastrointestinal disease. I.

Authors:  B W Badley
Journal:  Can Med Assoc J       Date:  1975-01-25       Impact factor: 8.262

Review 3.  Carbenoxolone sodium.

Authors:  W Sircus
Journal:  Gut       Date:  1972-10       Impact factor: 23.059

Review 4.  Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; R Spencer; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.